I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Participants will repeat the screening tests during the study. Participants will receive nilotinib and paclitaxel. The drugs are given in 28-day cycles. Nilotinib is a capsule taken by mouth twice a day. Paclitaxel will be given intravenously by peripheral line or central line once a week for the first 3 …
angiosarcoma
paclitaxel
pancreatic neuroendocrine tumor
prostate cancer
giant cell tumors
- 0 views
- 19 Feb, 2024